HIV Non-Occupational Post-Exposure Prophylaxis
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects
- Status
- COMPLETED
- Phase
- N/A
Study of the Effect of GS-6615 in Subjects With LQT-3
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study to Assess the Safety,Tolerability, and Pharmacokinetics of GS-6615 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Phase Ib Study of SC Milatuzumab in SLE
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study of Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 Pharmacokinetics
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1b Safety, Tolerability, and PK Study to Assess GS-5737 in Subjects With CF
- Status
- COMPLETED
- Phase
- PHASE1
Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection
- Status
- COMPLETED
- Phase
- PHASE3
Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
SCOPE: Strategies to Combine PrEP With Prevention Efforts
- Status
- WITHDRAWN
- Phase
- NA
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE2
Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1 Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Intravesical Cidofovir for Hemorrhagic Cystitis
- Status
- COMPLETED
- Phase
- PHASE1
Impact of Ranolazine on Coronary Microcirculatory Resistance
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants
- Status
- COMPLETED
- Phase
- PHASE3